Thermo Fisher Scientific (TMO) Revenue (2009 - 2026)

Thermo Fisher Scientific has disclosed Revenue across 18 years of filings, most recently posting $11.0 billion for Q1 2026.

• Quarterly Revenue rose 6.18% year-over-year to $11.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.2 billion (up 5.36% YoY) and the FY2025 annual result came in at $44.6 billion, up 3.91% from the prior year.
• Revenue fell to $11.0 billion in Q1 2026, from $12.2 billion in the prior quarter.
• Over five years, Revenue peaked at $12.2 billion in Q4 2025 and troughed at $10.3 billion in Q1 2024.
• A 5-year average of $11.0 billion and a median of $10.9 billion in 2025 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue increased 19.3% — and 2023, when it fell 9.38%.
• Tracing TMO's Revenue over 5 years: stood at $11.5 billion in 2022, then dropped by 4.93% to $10.9 billion in 2023, then increased by 4.68% to $11.4 billion in 2024, then gained by 7.2% to $12.2 billion in 2025, then slipped by 9.91% to $11.0 billion in 2026.
• Business Quant data shows TMO's Revenue at $11.0 billion in Q1 2026, $12.2 billion in Q4 2025, and $11.1 billion in Q3 2025.